OTCMKTS:PHGUF

Pharming Group Stock Forecast, Price & News

$1.15

0.00 (0.00 %)

(As of 07/30/2021 09:30 AM ET)

Add

Compare

Today's Range

$1.15

▼

$1.15

50-Day Range

$1.08

▼

$1.26

52-Week Range

$1.05

▼

$1.85

Volume55,300 shs

Average Volume5,325 shs

Market Capitalization$719.76 million

P/E Ratio23.00

Dividend YieldN/A

Beta1.77

30 days | 90 days | 365 days | Advanced Chart

Receive PHGUF News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter.

About Pharming Group

Pharming Group N.V., a specialty pharmaceutical company, develops products for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema. It also engages in the development of rhC1INH for the treatment of pre- eclampsia, acute kidney injury, and COVID-19; leniolisib, a phosphoinositide 3-kinase delta (PI3K delta) to treat patients with activated activated PI3K delta syndrome; and alpha-glucosidase therapy for the treatment of pompe and fabry diseases. The company has development collaboration and license agreement with Novartis. Pharming Group N.V. is headquartered in Leiden, the Netherlands.

Pharming Group (OTCMKTS:PHGUF) Sees Large Decline in Short Interest
July 30, 2021 | americanbankingnews.com

Pharming Group (OTCMKTS:PHGUF) Share Price Crosses Below 50 Day Moving Average of $1.20
July 9, 2021 | americanbankingnews.com

Pharming announces completion of enrolment in Phase II/III study with leniolisib for activated PI3K delta syndrome
June 23, 2021 | finance.yahoo.com

Pharming Group reports financial results for the first quarter of 2021
May 13, 2021 | finance.yahoo.com

Pharming Group announces the intention to nominate three Non-Executive Directors to the Board of Directors
March 23, 2021 | markets.businessinsider.com

Pharming Group to present at 31st Annual Oppenheimer Healthcare Conference
March 16, 2021 | finance.yahoo.com

Pharming Group to Present at BioCapital Europe 2021
March 11, 2021 | finance.yahoo.com

Pharming Group NV Stock , PHGUF
December 25, 2020 | markets.businessinsider.com

News for Pharming Group NV
December 23, 2020 | markets.businessinsider.com

Pharming Group Is A COVID-19 Hedge
December 22, 2020 | seekingalpha.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Tobacco products
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PHGUF
Previous SymbolOTC:PHGUF
CUSIPN/A
CIKN/A
Webwww.pharming.com
Phone31-0-71-524-7400
Employees262
Year FoundedN/A

Sales & Book Value

Annual Sales$212.10 million
Price / Sales3.39
Cash Flow$0.07 per share
Price / Cash Flow15.63
Book Value$0.27 per share
Price / Book4.26

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares625,880,000
Market Cap$719.76 million
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

1.30 out of 5 stars

Medical Sector

1237th out of 2,220 stocks

Tobacco Products Industry

5th out of 8 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Pharming Group.

4.0 Community Rank

Outperform Votes
Pharming Group has received 171 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Pharming Group has received 111 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Pharming Group has received 60.64% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Pharming Group and other stocks. Vote “Outperform” if you believe PHGUF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PHGUF will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Pharming Group does not currently pay a dividend.
Dividend Growth
Pharming Group does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Pharming Group insiders have not sold or bought any company stock.

2.5 Earnings and Valuation

Earnings Growth
Earnings for Pharming Group are expected to grow by 28.57% in the coming year, from $0.07 to $0.09 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Pharming Group is 23.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.00.
Price to Earnings Ratio vs. Sector
The P/E ratio of Pharming Group is 23.00, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 39.68.
Price to Book Value per Share Ratio
Pharming Group has a P/B Ratio of 4.26. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Pharming Group (OTCMKTS:PHGUF) Frequently Asked Questions

What stocks does MarketBeat like better than Pharming Group?

Wall Street analysts have given Pharming Group a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Pharming Group wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Pharming Group?

Pharming Group saw a drop in short interest in July. As of July 15th, there was short interest totaling 12,166,700 shares, a drop of 37.2% from the June 30th total of 19,367,700 shares. Based on an average daily trading volume, of 4,000 shares, the short-interest ratio is presently 3,041.7 days.
View Pharming Group's Short Interest.

How were Pharming Group's earnings last quarter?

Pharming Group (OTCMKTS:PHGUF) posted its earnings results on Thursday, March, 5th. The biotechnology company reported $0.05 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.04 by $0.01. Pharming Group had a net margin of 18.47% and a trailing twelve-month return on equity of 22.51%.
View Pharming Group's earnings history.

How has Pharming Group's stock been impacted by Coronavirus (COVID-19)?

Pharming Group's stock was trading at $1.35 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, PHGUF shares have decreased by 14.8% and is now trading at $1.15.
View which stocks have been most impacted by COVID-19.

Who are Pharming Group's key executives?

Pharming Group's management team includes the following people:

Dr. Sijmen de Vries M.B.A., M.D., MBA, CEO & Exec. Director (Age 62, Pay $1.24M)
Dr. Bruno M. L. Giannetti, Consultant (Age 69, Pay $747.21k)
Mr. Jeroen Wakkerman, Chief Financial Officer (Age 52)
Ms. Mireille Sanders M.Sc., Chief Operations Officer (Age 53)
Susanne Embleton, Investor Relations Mang.
Mr. Ruud Van Outersterp, Chief Ethics & Compliance Officer
Mr. Anurag Relan, Chief Medical Officer (Age 49)
Mr. Paul Th. Jansse, VP & Head of Non-US Commercial Operations (Age 52)
Mr. Stephen Toor, Chief Commercial Officer & GM of Americas (Age 50)

Who are some of Pharming Group's key competitors?

Some companies that are related to Pharming Group include Lonza Group (LZAGY), Imperial Brands (IMBBY), Turning Point Brands (TPB), Healthier Choices Management (HCMC) and Gilla (GLLA).
View all of PHGUF's competitors.

What is Pharming Group's stock symbol?

Pharming Group trades on the OTCMKTS under the ticker symbol "PHGUF."

How do I buy shares of Pharming Group?

Shares of PHGUF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pharming Group's stock price today?

One share of PHGUF stock can currently be purchased for approximately $1.15.

How much money does Pharming Group make?

Pharming Group has a market capitalization of $719.76 million and generates $212.10 million in revenue each year. The biotechnology company earns $37.74 million in net income (profit) each year or $0.06 on an earnings per share basis.

How many employees does Pharming Group have?

Pharming Group employs 262 workers across the globe.

What is Pharming Group's official website?

The official website for Pharming Group is www.pharming.com.

Where are Pharming Group's headquarters?

Pharming Group is headquartered at Darwinweg 24, Leiden P7, 2333 CR.

How can I contact Pharming Group?

Pharming Group's mailing address is Darwinweg 24, Leiden P7, 2333 CR. The biotechnology company can be reached via phone at 31-0-71-524-7400 or via email at [email protected]

This page was last updated on 8/2/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here